Market Summary - December 31, 2025
On December 31, 2025, U.S. stocks opened lower, marking the fourth consecutive day of declines as traders wrapped up a month characterized by significant price fluctuations. Despite the downturn, the market remains on track for strong gains throughout 2025.
Market Indices Performance
| Index | Change (Up/Down) | Percentage Change (%) | Last Value |
|---|---|---|---|
| DJ Industrials | -154.15 | 0.32% | 48,212 |
| S&P 500 | -20.70 | 0.30% | 6,875 |
| Nasdaq | -62.87 | 0.27% | 23,356 |
| Russell 2000 | -6.58 | 0.26% | 2,494 |
Market Highlights
The bond market is set to close early at 2:00 PM ET, while the stock market will remain open until 4:00 PM ET. Precious metals, including silver and gold, experienced a decline following the CME Group's announcement of increased margin requirements for precious metals, marking the second hike in a short period. Despite this, precious metals are still expected to show significant gains for the year.
Currency and Commodities
| Commodity/Currency | Change | Last Value |
|---|---|---|
| WTI Crude | +0.05 | 58.00 |
| Brent | +0.01 | 61.34 |
| Gold | -42.30 | 4,344.00 |
| EUR/USD | -0.0012 | 1.1734 |
| JPY/USD | +0.50 | 156.89 |
| 10-Year Note | +0.012 | 4.14% |
Stock Performers
Gainers
- AXSM: +17% - Received positive feedback from the FDA regarding NDA submission for AXS-12.
- NKE: +2% - CEO Elliott Hill purchased shares valued at $1M.
- ONDS: +13% - Announced $10M in new purchase orders.
- VNDA: +31% - FDA approved drug Nereus for motion-induced vomiting.
- WULF: +3% - Upgraded to Outperform with a target price increase.
Laggers
- CORT: -51% - FDA declined to approve relacorilant therapy.
- CRK: -2% - Natural gas producers fell with lower prices.
- SLV: -4% - Prices of gold and silver pulled back due to margin hikes.
Overall, the market is experiencing low trading volumes with all eleven S&P sectors currently in the red as the year comes to a close.